Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
University of Arizona · University of South Florida · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
883
total citations
- FWCI
- 18.22
- Percentile
- 100%
- References
- 53
Citations per year
Authors
11Topics & keywords
Topics
Keywords
- Boceprevir
- Biology
- Virology
- Protease
- Viral replication
- Calpain
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Replication (statistics)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of EnergyAwards: AC02-06CH11357, contract DE-AC02-06CH11357, DE-AC02, 06CH11357, DE-AC02-06CH11357, DE-AC02-
- DODivision of Intramural Research, National Institute of Allergy and Infectious DiseasesAwards: N01-AI-30048, AI147325
- UOUniversity of ChicagoAward: DE-AC02-06CH11357
- ABArizona Biomedical Research CommissionAward: ADHS18-198859
- NINational Institutes of HealthAwards: AI147325, R35 GM128624, DE-AC02-06CH11357
- ARAdvanced Research Projects Agency - EnergyAward: DE-AC02-06CH11357
- NINational Institute of General Medical SciencesAwards: R35 GM128624, DE-AC02-06CH11357, GM128624
- NINational Institute of Allergy and Infectious DiseasesAward: AI147325
- BABiological and Environmental ResearchAward: DE-AC02-06CH11357
- ANArgonne National LaboratoryAwards: DE-AC02, 06CH11357, AC02-06CH11357, under contract DE-AC02-06CH11357